NUTEX Investments (BUD:NUTEX) Buyback Yield %: -0.16 (As of Jul. 09, 2026)


BUD:NUTEX NUTEX Investments PLC BUD:NUTEX
52 GF Score
Price Ft12.70
GF Value Ft13.80
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is NUTEX Investments Buyback Yield %?

NUTEX Investments BUD:NUTEX -5.22% 52 Buyback Yield % is -0.16 as of Jul. 09, 2026. GuruFocus rates BUD:NUTEX with a GF Score™ of 52/100 and a GF Value™ of Ft13.80 (Fairly Valued). The stock has 3 warning signs investors should review. Among 291 Drug Manufacturers companies, NUTEX Investments ranks better than 55.33% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

NUTEX Investments's current buyback yield was -0.16%.

NUTEX Investments Buyback Yield % Historical Data

* Premium members only.

The historical data trend for NUTEX Investments's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NUTEX Investments Buyback Yield % Chart

NUTEX Investments Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -70.23 0.00 0.00 12.06 -0.19

NUTEX Investments Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 12.06 -0.16 -0.19

BUD:NUTEX vs ZTS, UTHR, VTRS: Buyback Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NUTEX Investments Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's Buyback Yield % falls into.


BUD:NUTEX
52GF Score
NUTEX Investments PLC BUD:NUTEX
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NUTEX Investments Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

NUTEX Investments's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 3.5) / 1821.554
=-0.19%

NUTEX Investments's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 3.5) / 1821.554
=-0.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -0.16 mean?
NUTEX Investments (BUD:NUTEX) has a Buyback Yield % of -0.16 as of Jul. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on NUTEX Investments and its competitors. According to the industry distribution chart, NUTEX Investments ranks #130 out of 291 companies in the Drug Manufacturers industry, placing it in the top 44.7%.
Is NUTEX Investments' Buyback Yield % too high?
NUTEX Investments' current Buyback Yield % is -0.16. Based on the distribution chart, NUTEX Investments ranks #130 out of 291 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, NUTEX Investments has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does NUTEX Investments' Buyback Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, NUTEX Investments ranks #130 out of 291 companies for Buyback Yield %. This puts NUTEX Investments in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on NUTEX Investments and its competitors. NUTEX Investments's current Buyback Yield % is -0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NUTEX Investments stock overvalued right now?
Based on GuruFocus' analysis, NUTEX Investments (BUD:NUTEX) is currently considered Fairly Valued. The stock's GF Value™ is Ft13.80, compared to a current price of Ft12.70 — trading 8% below its estimated fair value. The current Buyback Yield % is -0.16. NUTEX Investments' overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For NUTEX Investments (BUD:NUTEX), the current Buyback Yield % is -0.16 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NUTEX Investments (BUD:NUTEX) Overvalued in 2026?

Based on GuruFocus' analysis, NUTEX Investments stock appears to be undervalued. The current stock price of Ft12.70 is trading 8% below its estimated GF Value™ of Ft13.80. GuruFocus considers NUTEX Investments to be Fairly Valued.

Key valuation signals for BUD:NUTEX:

  • Buyback Yield %: -0.16
  • GF Value™: Ft13.80 vs. price of Ft12.70 (8% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the BUD:NUTEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NUTEX Investments Business Description

Address Telepes u. 53., Budapest, HUN, 1147
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.
52GF Score

Get the complete analysis for BUD:NUTEX

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft12.70
Price
Ft13.80
GF Value